---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-002522"
form_type: "8-K"
ticker: "SBFM"
cik: "0001402328"
company_name: "Sunshine Biopharma Inc."
filed_at: "2023-04-19T23:59:59+00:00"
generated_at: "2026-06-16T23:29:52.451722+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Sunshine Biopharma amends bylaws to set quorum at one-third of outstanding shares

## Summary
- Quorum for shareholder meetings now one-third of outstanding common voting stock.
- Amendment adopted on April 17, 2023; no other bylaw changes disclosed.
- Fiscal year unchanged; no impact on capital structure or business operations.

## SEC filing metadata
- accession: 0001683168-23-002522
- form_type: 8-K
- ticker: SBFM
- cik: 0001402328
- company_name: Sunshine Biopharma Inc.
- filed_at: 2023-04-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402328/000168316823002522/0001683168-23-002522-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402328/000168316823002522/sunshine_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-002522
- JSON: https://secwatch.observer/filing/0001683168-23-002522.json
- Plain text: https://secwatch.observer/filing/0001683168-23-002522.txt

## Key facts
- Governance Changes
  Sunshine Biopharma Inc.: Amendment to bylaws changing the quorum requirement for common voting stock to one-third of outstanding shares (effective 2023-04-17).
  - Change: bylaw amendment
  - Effective: 2023-04-17
  source text: On April 17, 2023, Sunshine Biopharma, Inc. (the “Company”) adopted an amendment to the Company’s bylaws. Pursuant to the amendment, one-third of the outstanding shares of the Company's common voting stock will constitute a quorum.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1402328/000168316823002522/0001683168-23-002522-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.